José Garnacho Montero-rekin lankidetzan egindako argitalpenak (22)

2024

  1. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

    Critical Care, Vol. 28, Núm. 1

2023

  1. Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation

    Intensive Care Medicine

  2. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  3. Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 21

2022

  1. Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 475-481

  2. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  3. One-year mortality after ICU admission due to COVID-19 infection

    Intensive Care Medicine

  4. Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study

    Medicina Intensiva, Vol. 46, Núm. 4, pp. 179-191

  5. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

  6. Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

    Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort

    Chest, Vol. 160, Núm. 1, pp. 187-198

  3. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

  4. Vaccinated patients admitted in icu with severe pneumonia due to sars-cov-2: A multicenter pilot study

    Journal of Personalized Medicine, Vol. 11, Núm. 11

2020

  1. From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic

    Medicina Intensiva, Vol. 44, Núm. 8, pp. 509-512

  2. Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis

    Clinical Microbiology and Infection, Vol. 26, Núm. 3, pp. 358-365

2019

  1. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): An investigator-driven, open-label, randomized, noninferiority controlled trial

    Critical Care, Vol. 23, Núm. 1

2018

  1. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

  2. Initial antifungal strategy reduces mortality in critically ill patients with candidemia: A propensity score-adjusted analysis of a multicenter study

    Critical Care Medicine, Vol. 46, Núm. 3, pp. 384-393

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1